Stroke | Xconomy

by in

Entry	Blogger	Date ▴	Location
Biotech Survival Index: Cash Running Low at Seattle Life Sciences Companies	Luke Timmerman	11/13/08	Seattle
Tysabri’s Roots at the “Hutch,” MediQuest Spurned by FDA, ZymoGenetics Drug Passes Test, & More Seattle-Area Life Sciences News	Luke Timmerman	11/06/08	Seattle
Northstar, Conserving Cash, Will Have $66M in Cash at Year-End	Luke Timmerman	11/05/08	Seattle
Northstar Gets OK For Second Depression Study	Luke Timmerman	10/14/08	Seattle
Northstar Neuroscience Cuts Jobs, Scraps Development of Stroke Treatment	Luke Timmerman	07/31/08	Seattle
Northstar Neuroscience Rejects Tang Capital’s Unsolicited Takeover Bid	Luke Timmerman	07/08/08	Seattle
Northstar Neuroscience Huddles to Consider Unsolicited Takeover Bid	Luke Timmerman	07/03/08	Seattle
Northstar Neuroscience Shares Climb on Tang Capital Bid	Luke Timmerman	07/02/08	Seattle
Page 1 of 1

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.